SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (7508)4/27/1998 10:25:00 PM
From: Frostman  Read Replies (2) of 23519
 
Vlad, Agreed! the 7/8 pull-back was appropriate given the environment. Even PFE got tapped on the shoulder today:

Source: Yahoo
<<Among the other movers in U.S. stocks, Pfizer Inc. (PFE - news) fell 4-13/16 to 113-7/16, despite news that its new impotence drug Viagra had 113,134 new prescriptions in the week ended April 17, its second week on the market.>>

ZONA went up in this down draft. Guess their script count was up this month, huh. Did it hit "1" already? Lordy.

Just don't raise the rates Greenspan, posturing is sufficient.(g)

Long VVUS,

Frostman

PS- Does this statement from the Tennessean seem strange?
<<Viagra is the first nonsurgical alternative to treating impotence, a
condition said to afflict up to 20 million men at some time during their lives. The new drug is taken orally an hour before intercourse, and enables men to achieve penile erections after sexual stimulation. Current treatments for impotence involve injections or devices inserted into the penis, options that are unpopular with many men.>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext